QIAGEN N.V. to release results for Q2 2023 and hold webcast
QIAGEN N.V. plans to release Q2 2023 results on August 8, followed by a conference call on August 9. Three options are available to join the call.
Positive
QIAGEN N.V. will release its Q2 2023 results, which could positively affect the stock price if the results exceed market expectations.
07/24/2023 - 07:41 AM
Venlo, The Netherlands, July 24, 2023 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced its plans to release results for the second quarter 2023.
Press release date / time: Tuesday, August 8, shortly after 22:05 Frankfurt time / 21:05 London time / 16:05 New York time .
Conference call date / time: Wednesday, August 9, at 15:00 Frankfurt time / 14:00 London time / 09:00 New York time.
Three options for joining the conference call
1.Register for call back connection - Click here: Connect me Service available 15 minutes before call start
2. Dial-in by phone U.S.: +1 646 828 8193 UK: +44 (0)330 165 3655 GER: +49 (0)69 6610 2490 Conference ID: 4878029 To avoid waiting time, please join the event conference 5-10 minutes prior to the start time.
3. Access the audio webcast - Click here: Access Webcast
A conference call replay will be available by using the following link:https://globalmeet.webcasts.com/starthere.jsp?ei=1596354&tp_key=0acb730754
Contact : IR@qiagen.com
About QIAGEN
QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily forensics). As of March 31, 2023, QIAGEN employed more than 6,200 people in over 35 locations worldwideFurther information can be found at http://www.qiagen.com .
source: QIAGEN N.V. category: Financial
When will QIAGEN N.V. release its Q2 2023 results?
QIAGEN N.V. plans to release its Q2 2023 results on August 8.
When is the conference call for QIAGEN N.V.'s Q2 2023 results?
The conference call for QIAGEN N.V.'s Q2 2023 results will be held on August 9.
How can I join the conference call?
There are three options to join the conference call: 1. Register for call back connection, 2. Dial-in by phone, or 3. Access the audio webcast.
What is the conference ID for the call?
The conference ID for the call is 4878029.
QGEN Rankings
#3158 Ranked by Stock Gains
QGEN Stock Data
Industry
Biological Product (except Diagnostic) Manufacturing
Sector
Manufacturing
Tags
Health Technology, Medical Specialties, Manufacturing, Biological Product (except Diagnostic) Manufacturing
Country
Netherlands
City
Venlo
About QGEN
qiagen is the leading global provider of sample to insight solutions to transform biological materials into valuable molecular insights. qiagen sample technologies isolate and process dna, rna and proteins from blood, tissue and other materials. assay technologies make these biomolecules visible and ready for analysis. bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. automation solutions tie these together in seamless and cost-effective molecular testing workflows. qiagen provides these workflows to more than 500,000 customers around the world in molecular diagnostics (human healthcare), applied testing (forensics, veterinary testing and food safety), pharma (pharmaceutical and biotechnology companies) and academia (life sciences research). as of june 30, 2015, qiagen employed approximately 4,400 people in over 35 locations worldwide. further information can be found at http://www.qiagen.com.